SIGN-UP HERE:
us02web.zoom.us/webinar/reg...
Parkinson's Disease-Medical Research Study- First Look at the Data from Intranasal Delivery of FGF-1
Description
Zhittya conducted the first-in-humans Parkinson's Disease Medical Research Study with the intranasal delivery of FGF-1. The test subjects started on May 3, 2022 and final dosing on May 30, 2022. Three weeks of follow-up observation allows Zhittya to have a first glimpse at the data to understand if the medicine and the delivery method were safe, and if there was any improvement in the health condition of the Parkinson's Disease test-subjects.
This webinar consists of raw data, first impressions, and observations for hints of improvement.
Time
Jun 23, 2022 03:00 PM in Pacific Time (US and Canada)